biotech
NicVax on Fast Track Status
Filed in archive Drugs, Vaccines and Therapeutics by ruth on March 13, 2006
BlogPicture

NicVax is a vaccine that acts by preventing the entry of nicotine into the brain, thus reducing the addictive effects of smoking. In November 2005, the smoking vaccine showed favorable clinical trial results. This week, manufacturer Nabi Biopharmaceuticals said that it has received fast-track status for NicVAX for nicotine addiction and smoking relapse.

"Smoking is the number one preventable cause of death in the western world, yet current smoking cessation therapies do not effectively treat the root cause of the addiction. We believe the vaccine approach inherent to NicVAX will provide clear patient advantages and a strong differentiation from currently marketed and development-stage products."


[Source: WP Herald]

Permalink: NicVax on Fast Track Status
Tags: nicotine  smoking  biotech  nicvax  track  fast+track  track+status  nicvax+fast 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/18020
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for NicVax on Fast Track Status:

  • Currently 9.00/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.00 out of 4 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!